• "We were highly impressed by the expert manner in which genOway’s scientists managed what I felt to be a rather..."

    > read full testimonial

    Prof. Simon C. ROBSON

    Director at Beth Israel Deaconess Medical Center

  • "genOway is the Mercedes Benz of transgenic outsourcing companies."

    > read full testimonial

    Prof. Robert TERKELTAUB

    Director at UC San Diego School of Medicine

  • "I am truly impressed with the responsiveness and help that I have obtained from genOway. It has been a pleasure to work..."

    > read full testimonial

    Prof. Bellur S. PRABHAKAR

    Associate Dean at University of Illinois College of Medicine

  • "We have worked with genOway in different projects for several years, and we are very impressed by their competence,..."

    > read full testimonial

    Prof. Maria T. DIAZ-MECO

    Lab Head at Sanford Burnham Prebys Medical Discovery Institute

  • "Mouse knock-out technology is an important step in cancer research, it provides relevant answers to scientific questions..."

    > read full testimonial


    IFOM-IEO Campus, University of Milan

  • "genOway has not only successful provided this service, but we have benefited a great deal from their consultation,..."

    > read full testimonial

    Dr. Paul RILEY

    Chair of Development and Cell Biology at Oxford University

  • "For more than two years we have worked with the scientific staff at genOway appreciating their fruitful and constant..."

    > read full testimonial

    Prof. Gianfranco SEBASTIO

    University of Naples Federico II

  • "genOway provides us with a very professional services within the expected timelines and high quality scientific..."

    > read full testimonial

    Prof. Gerd WALZ

    Director at Albert Ludwigs University Freiburg

  • "genOway is a leading company in the field of genetically modified mouse and rat models. Its technology platform is..."

    > read full testimonial

    Prof. Pier Paolo DI FIORE

    IFOM-IEO Campus, University of Milan

  • "genOway has carried out several projects for us. This collaboration has been very successful. Not just because we have..."

    > read full testimonial

    Prof. Arne KLUNGLAND

    Lab Head at Oslo University Hospital

  • "It goes without saying that knockout technologies are an indispensible research tool in Hepatology. In this regard we..."

    > read full testimonial

    Prof. Dr. Dieter HÄUSSINGER

    Director at Heinrich Heine University Düsseldorf

  • "genOway has really impressed me with the quality of its service and its competence. I would emphasize their reliability..."

    > read full testimonial

    Prof. Ruben PIO

    Director at CIMA, University of Navarra

  • "With the idea to develop a mouse model for the rare human disease ALD, we reached out to genOway to help us in finding..."

    > read full testimonial

    Dr. Stephan KEMP

    Associate Professor at Academic Medical Center (AMC)

  • "Leader for the development of transgenic mice and rats, genOway is a very reliable biotechnology company. Their main..."

    > read full testimonial

    Prof. Shomi BHATTACHARYA

    Director of Cabimer

  • "I ascertain that genOway has provided extremely efficient and competent services to us and we will very likely use them..."

    > read full testimonial

    Prof. Ludwig NEYSES

    Chair of Medicine at University of Manchester

  • "genOway has already supplied us with several difficult-to-make knockout cell lines. We are impressed by the speed and..."

    > read full testimonial

    Prof. Hans CLEVERS

    Director Research of Princess Maxima Center

  • "Without you it would have been impossible for us to establish this transgenic mouse from the EUCOMM ES cells. I was most..."

    > read full testimonial

    Dr. Matthias HUNDT

    Instructor at La Jolla Institute for Allergy & Immunology

  • "genOway has a professional attitude toward its customers. We had really appreciated their innovative technologies and..."

    > read full testimonial

    Prof. Ivan DIKIC

    Director at Goethe University Frankfurt am Main

  • "I have never witnessed such proactive behavior with customers. genOway truly understand our challenges and is equipped..."

    > read full testimonial

    Dr. Carla BOCCACCIO

    University of Torino Medical School

  • "IEO and genOway collaboration started some years ago while we were looking for collaborative and highly professional..."

    > read full testimonial

    Prof. Pier Giuseppe PELICCI

    Scientific Director of the European Institute of Oncology Milan


At a Glance

At a Glance

genOway specializes in genetic designs to serve genetically modified mice, rat and cell lines of the highest standards for academic and bio-pharmaceutical researchers in:

• 28 countries worldwide
• 380 academic institutions & 13 EU projects
• 170 Life Sciences companies
• 17 of the Top 20 pharma

What We Stand For

What We Stand For

"Thorough project assessment, in-depth scientific analysis of your current and future needs, a unique technology portfolio, excellence in production, and dedicated customer care are the core pillars that distinguish our service.
We translate your project into the most adapted and physiologically relevant research model."

Alexandre Fraichard, Founder & GM

Immune Checkpoint Models

Humanized mouse models to assess the efficacy of immuno-oncology compounds

> Access the catalog Immune Checkpoint Models

Immunodeficient Mouse Strains

Most adapted mouse model to study and predict human immune responses in vivo

> Access the portfolio Immunodeficient Mouse Strains

Knockout Mouse Catalog

Includes more than 2000 ready-to-use conditional Knockout and reporter mouse strains

> Find your ready-to-use model Knockout Mouse Catalog

Customized Rat Models

Knockouts/Knockins in inbred and outbred strains, through advanced CRISPR technology

> Read on for more detail Customized Rat Models

Customized Mouse Models...

Designed for high physiological relevancy and to specifically address your scientific questions

> Read on for more detail Customized Mouse Models...

Cell Line Engineering...

Using CRISPR/Cas9 editing, our platform is fully adapted to modify your in-house cell line

> Read on for more detail Cell Line Engineering...

Latest Clients Publications

  • Pan D et al.

    Plast Reconstr Surg. 2021 Jul 1

    | Long Acellular Nerve Allografts Cap Transected...

  • Lipovsky A et al.

    J Invest Dermatol. 2021 Jul

    | ACT1 Is Required for Murine IL-23-Induced...

  • Saxena AR et al.

    Nat Med. 2021 Jun

    | Danuglipron (PF-06882961) in type 2 diabetes: a...

  • Wang Q et al.

    Nat Commun. 2021 May 26

    | CaMKII oxidation is a critical performance/disease...

  • Helmer RA et al.

    PLoS One. 2021 May 19

    | Helicase-like transcription factor-deletion from...